MiniMed Group, Inc. (MMED): Insider Trading, Congress Trades & Research | Tormere
MMED
$16.71-7.98%
MiniMed Group, Inc.
Market Cap
$4.7B
Live price × SEC shares (Sep 3, 2026)
Sector
Health Care
Industry
Health Care
Beta (raw)
—
Insufficient price history
P/E (TTM)
N/M
TTM to Jul 2026 · negative earnings
P/S (TTM)
—
Mkt cap / TTM revenue
P/B
1.3
Mkt cap / shareholders' equity
EV/EBITDA (TTM)
—
EV / TTM EBITDA
Loading…
Financial Statements
USD millions
Jul 2025
Jul 25, 2025
Q3 FY2026
Jan 23, 2026
Q4 FY2026
Apr 24, 2026
Q1 FY2027
Jul 31, 2026
TTM
Jul 31, 2026
Revenue
723
790
837
843
Cost of revenue
314
428
357
378
Gross profit
409
362
480
465
Research & development
125
114
99
115
Selling, general & administrative
283
309
299
312
Operating income
(13)
(100)
(93)
5
Pretax income
(13.0)
(99.0)
(92.0)
4.0
Income tax
3.0
12.0
93.0
4.0
Net income
(19)
(119)
(185)
0
(309)
EPS (basic) ($)
(0.08)
(0.47)
0.00
(1.22)
EPS (diluted) ($)
(0.08)
(0.47)
0.00
(1.22)
Weighted avg. shares (basic)
253
253
281
Weighted avg. shares (diluted)
253
253
281
Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in millions. Latest: 10-Q filed Sep 8, 2026, period ended Jul 31, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 2 more quarters, back to Jan 2025, with Tormere Pro.
